The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

David F. Woodward

Dept. of Biological Sciences RD3-2B

Allergan

Inc., 2525 Dupont Dr.

Irvine

[email]@allergan.com

Name/email consistency: high

 
 
 
 
 
 
 

Affiliations

  • Dept. of Biological Sciences RD3-2B, Allergan, Inc., 2525 Dupont Dr., Irvine. 2011
  • Department of Biological Sciences, Allergan, Inc, Irvine, California 92612-1599, USA. 2003 - 2009
  • Allergan Inc., 2525 Dupont Drive, Irvine, CA 92612, USA. 2001 - 2008

References

  1. International Union of Basic and Clinical Pharmacology. LXXXIII: Classification of Prostanoid Receptors, Updating 15 Years of Progress. Woodward, D.F., Jones, R.L., Narumiya, S. Pharmacol. Rev. (2011) [Pubmed]
  2. Prostanoid EP4 receptor stimulation produces ocular hypotension by a mechanism that does not appear to involve uveoscleral outflow. Woodward, D.F., Nilsson, S.F., Toris, C.B., Kharlamb, A.B., Nieves, A.L., Krauss, A.H. Invest. Ophthalmol. Vis. Sci. (2009) [Pubmed]
  3. Prostamides (prostaglandin-ethanolamides) and their pharmacology. Woodward, D.F., Liang, Y., Krauss, A.H. Br. J. Pharmacol. (2008) [Pubmed]
  4. The pharmacology and therapeutic relevance of endocannabinoid derived cyclo-oxygenase (COX)-2 products. Woodward, D.F., Carling, R.W., Cornell, C.L., Fliri, H.G., Martos, J.L., Pettit, S.N., Liang, Y., Wang, J.W. Pharmacol. Ther. (2008) [Pubmed]
  5. Identification of an antagonist that selectively blocks the activity of prostamides (prostaglandin-ethanolamides) in the feline iris. Woodward, D.F., Krauss, A.H., Wang, J.W., Protzman, C.E., Nieves, A.L., Liang, Y., Donde, Y., Burk, R.M., Landsverk, K., Struble, C. Br. J. Pharmacol. (2007) [Pubmed]
  6. Bimatoprost: a novel antiglaucoma agent. Woodward, D.F., Phelps, R.L., Krauss, A.H., Weber, A., Short, B., Chen, J., Liang, Y., Wheeler, L.A. Cardiovasc. Drug. Rev (2004) [Pubmed]
  7. Pharmacological characterization of a novel antiglaucoma agent, Bimatoprost (AGN 192024). Woodward, D.F., Krauss, A.H., Chen, J., Liang, Y., Li, C., Protzman, C.E., Bogardus, A., Chen, R., Kedzie, K.M., Krauss, H.A., Gil, D.W., Kharlamb, A., Wheeler, L.A., Babusis, D., Welty, D., Tang-Liu, D.D., Cherukury, M., Andrews, S.W., Burk, R.M., Garst, M.E. J. Pharmacol. Exp. Ther. (2003) [Pubmed]
  8. The pharmacology of bimatoprost (Lumigan). Woodward, D.F., Krauss, A.H., Chen, J., Lai, R.K., Spada, C.S., Burk, R.M., Andrews, S.W., Shi, L., Liang, Y., Kedzie, K.M., Chen, R., Gil, D.W., Kharlamb, A., Archeampong, A., Ling, J., Madhu, C., Ni, J., Rix, P., Usansky, J., Usansky, H., Weber, A., Welty, D., Yang, W., Tang-Liu, D.D., Garst, M.E., Brar, B., Wheeler, L.A., Kaplan, L.J. Surv. Ophthalmol (2001) [Pubmed]
 
WikiGenes - Universities